Ignite Creation Date:
2025-12-18 @ 4:14 AM
Ignite Modification Date:
2025-12-23 @ 6:58 PM
Study NCT ID:
NCT00748709
Status:
None
Last Update Posted:
2025-02-11 00:00:00
First Post:
2008-09-08 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification.
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2010-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2008-09-08 00:00:00
First Submit QC Date:
None
Study First Post Date:
2008-09-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-08 00:00:00
Results First Submit QC Date:
None
Results First Post Date:
2013-10-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-21 00:00:00
Last Update Post Date:
2025-02-11 00:00:00
Last Update Post Date Type:
ACTUAL